Cargando…
Clinical and Immunologic Profiles in Incomplete Lupus Erythematosus and Improvement with Hydroxychloroquine Treatment
Objective. The study goals were to evaluate performance of SLE classification criteria, to define patients with incomplete lupus erythematosus (ILE), and to probe for features in these patients that might be useful as indicators of disease status and hydroxychloroquine response. Methods. Patients wi...
Autores principales: | Olsen, Nancy J., McAloose, Carl, Carter, Jamie, Han, Bobby Kwanghoon, Raman, Indu, Li, Quan-Zhen, Liao, Duanping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225311/ https://www.ncbi.nlm.nih.gov/pubmed/28116147 http://dx.doi.org/10.1155/2016/8791629 |
Ejemplares similares
-
Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE): study protocol for a randomized controlled trial
por: Olsen, Nancy J., et al.
Publicado: (2018) -
Genetic load in incomplete lupus erythematosus
por: Slief, Matt, et al.
Publicado: (2023) -
Hydroxychloroquine ototoxicity in a patient with systemic lupus
erythematosus
por: Fernandes, Mariana Rita de Novaes, et al.
Publicado: (2018) -
Hydroxychloroquine-induced retinal toxicity in systemic lupus erythematosus
por: Piggott, Kisha D, et al.
Publicado: (2018) -
Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge
por: Dima, Alina, et al.
Publicado: (2022)